Nalaganje...
Immunotherapy of advanced renal cell carcinoma: Current and future therapies
Previously a malignancy with few therapeutic options, metastatic renal cell carcinoma (mRCC) treatment is rapidly evolving. Although cytokine therapies (interferon-a, interleukin-2) have been used less frequently over the past decade, recent approval of an immune checkpoint inhibitor, nivolumab, has...
Shranjeno v:
| izdano v: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215367/ https://ncbi.nlm.nih.gov/pubmed/27494417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1212794 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|